WELLS FARGO & COMPANY/MN
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$555,035
+$384,579 QoQ
Shares Held
41,732
+127.9% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,528,481 across 417 Biotechnology names. FDMT ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in FDMT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $555,035 | 41,732 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $170,456 | 18,309 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $349,650 | 46,620 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $269,294 | 30,989 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $96,337 | 25,967 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $76,402 | 23,654 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $143,995 | 25,852 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $198,785 | 18,389 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $382,962 | 18,245 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $457,031 | 14,345 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $248,671 | 12,274 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $408,569 | 32,095 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $706,229 | 39,083 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $481,112 | 27,988 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,442 | 200 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,162 | 269 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,825 | 548 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $167,514 | 11,079 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $443,933 | 20,234 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $207,237 | 7,684 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,865 | 825 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $105,847 | 2,440 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||